Börse von finanzen.net | Aktien-Nachrichten | Marktberichte

DAX	6.050	-3,4%	Dow	12.119	-2,2%	Euro	1,2432	0,6%
ESt50	2.069	-2,4%	Nas	2.748	-2,8%	Öl	98,82	-2,8%
TDax	730,9	-2,7%	Nikkei	8.440	-1,2%	Gold	1.626	4,2%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds	Senden
Historisch	Realtime Push	myNews neu		IR-Daten	Anleihen	handeln

21.05.12	Cellectis stem cells today proudly announces the launch of the world’s very first human iPS cell-derived hepatocyte product
02.04.12	Appointment of Mathieu Simon, MD, to the Position of Senior Vice-President of Cellectis Group
13.02.12	Cellectis announces the redemption of the bonds redeemable into shares subscribed by the FSI and Pierre Bastid for a total of €50 million
31.01.12	Cellectis Plant Sciences Announces the Signature of a Strategic Partnership with SESVanderHave in Sugar Beet
30.01.12	Changes in the Group's Scientific Division and Appointment of the CEO of Cellectis Plant Sciences
16.01.12	Medicago and Cellectis Enter into Research Agreement to Improve Therapeutic Proteins Using Nuclease Technology
09.01.12	Cellectis Launches a Partnership with Total for Exploratory Research into Microalgae-Based Substitutes for Oil Products
03.01.12	Cellectis plant sciences and Bayer CropScience strengthen genome engineering partnership
08.12.11	Cellectis bioresearch and Syngene Announce Partnership on the Development of Customized Cell Lines
08.12.11	Starbucks Enters Five New Cities Across Mainland China

05.12.11	Cellectis Signs a License Agreement Under Patents Covering Uses of Homologous Recombination With Global Pharmaceutical Company
07.11.11	Cellectis Announces the Final Completion of the Acquisition of Cellartis and €50 Million Financing Round Reserved for the FSI and Mr. Pierre Bastid
02.11.11	Cellectis shareholders approve the acquisition of Cellartis.
24.10.11	Appointment of Philippe Valachs as Cellectis’ General Secretary
06.10.11	Cellectis: 2011 half-year earnings
06.10.11	USANA Schedules Third Quarter Earnings Release and Conference Call
03.10.11	Cellectis Issues Statement Regarding Patent Suits on Meganuclease Technology
24.08.11	Cellectis bioresearch Grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock
20.07.11	Cellectis bioresearch and Lonza Achieve Significant Milestone on CHO-K1SV GS Knock-Out
11.07.11	Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis Therapeutics
29.06.11	Cellectis and Pregenen Sign Collaboration Agreement for the Development of Meganucleases
27.06.11	Soundelux's Per Hallberg and Karen Baker Landers Explore the Sounds of Good and Evil in Warner Bros.' Epic "Green Lantern"
27.06.11	André Choulika to Serve as Both Chairman and CEO of Cellectis
06.06.11	Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection
18.05.11	Cellectis Bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan
11.04.11	Cellectis Strengthens Management Team to Support Stem Cell Activities
05.04.11	Cellectis and Caisse des Dépôts sign agreement on a project for the industrial development of iPS cells
04.04.11	Cellectis receives payment for license to homologous recombination patents
31.03.11	Cellectis Publishes 2010 Financial Results
08.03.11	Cellectis and the Etablissement Français du Sang Launch StemRed, a Program to Produce Red Blood Cells from Stem Cells
08.02.11	Cellectis to Present at the Annual Congress "Gene Targeting” in Vienna
20.01.11	Cellectis Acquires Exclusive License to TAL Effector Patents from University of Minnesota
19.01.11	Cellectis’ Meganuclease Technology Used to Efficiently Prevent Viral Infection
09.12.10	Cellectis bioresearch Announces the First TGCA Winner
09.12.10	Pantone Reveals Color of the Year for 2011: PANTONE 18-2120 Honeysuckle
07.12.10	Cellectis Bioresearch Signs Non-Exclusive License with Evrogen for Access to Fluorescent Proteins
07.12.10	Visa Mobile Contactless Payments Solution Certified for Commercial Use
02.12.10	Cellectis grants Harvard Bioscience a License to CytoPulse Electroporation Instruments
30.11.10	L-3 to Present at Credit Suisse Aerospace and Defense Conference
30.11.10	Cellectis Hosts Inaugural R&D Day

Finanzen.net

CELLECTISAct Nom Aktie [WKN: A0MKPR / ISIN: FR0010425595]

Hinweis

Newssuche

ALLE Nachrichten zur CELLECTISAct. Nom.

Anzeige

ANZEIGE